Health Care Redesign – Page 12 – medicarereport.org

Sunday, November 24, 2024

Latest:

Health Care Redesign Medicare Advantage

Eileen Cook October 3, 2023 Alignment Healthcare, Instacart, Medicare Advantage

Instacart, Alignment to launch co-branded Medicare Advantage plan

(By Jakob Emerson for Becker’s Hospital Review) Grocery delivery company Instacart is launching a co-branded Medicare Advantage plan next year

CMS Health Care Finance Health Care Redesign Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook September 27, 2023September 27, 2023 CMS, Healthcare Costs, medicare, Medicare Advantage, Medicare Drug Price Negotiation Program, Medicare Part D

How Medicare’s New Drug Price Negotiation Program Could Expand Access to Selected Drugs

(By Juliette Cubanski, Anthony Damico, and Tricia Neuman for The Kaiser Family Foundation Published: Sep 26, 2023) Medicare recently announced

Health Care Redesign Legislative Update Medicare Advantage

Eileen Cook September 22, 2023September 22, 2023 Healthcare redesign, Legislation, Medicare Advantage, Medicare Advantage Supplemental benefits, Whole Health in Medicare Advantage Act

AHIP backs legislation expanding Medicare Advantage supplemental benefits

(By Rylee Wilson for Becker’s Hospital Review) Two lawmakers are introducing legislation that would expand the scope of supplemental benefits

Health Care Finance Health Care Redesign Part D/Prescription Drugs

Eileen Cook September 8, 2023September 8, 2023 Healthcare Costs, Medicare Drug Price Negotiation Program, Medicare Part D

How the drug price negotiation program could affect Medicare Part D beneficiaries

By Mariana Socal for STAT) After the recent announcement of the first 10 drugs selected for Medicare price negotiation, much

Affordable Care Act (ACA)Health Care Finance Health Care Redesign Health Insurance HHS

Eileen Cook September 5, 2023September 5, 2023 ACA, Colorado reinsurance, Healthcare Finance, HHS, Public Option

Biden administration gives $245M to Colorado reinsurance, public option programs

(By Jakob Emerson for Becker’s Hospital Review) HHS and the Treasury Department are providing $245 million in funding to the

Health Care Finance Health Care Redesign Health Insurance Part D/Prescription Drugs

Eileen Cook September 1, 2023September 5, 2023 Drug costs, GoodRx

GoodRx launches patient insurance check tool for providers

(By Jakob Emerson for Becker’s Hospital Review) GoodRx has launched a new feature that allows providers to check a patient’s

CMS Health Care Finance Health Care Redesign Medicare - General Part D/Prescription Drugs

Eileen Cook August 31, 2023September 5, 2023 CMS, Healthcare Costs, medicare, Medicare Drug Price Negotiation Program, Medicare Part D

5 Things to Know About the New Drug Pricing Negotiations

(By Arthur Allen, Rachana Pradhan, and David Hilzenrath for KFF Health News) The Biden administration has picked the first 10

CMS Health Care Finance Health Care Redesign Medicare - General Part D/Prescription Drugs

Eileen Cook August 29, 2023August 29, 2023 0 Comments CMS, medicare, Medicare Drug Price Negotiation Program, Medicare Part D, Prescription drug costs

Here are the first 10 drugs that Medicare will target for price cuts

(By Selena Simmons-Duffin and Deepa Shivaram for NPR) The Biden administration released its list of the first 10 drugs that

CMS Health Care Finance Health Care Redesign Part D/Prescription Drugs

Eileen Cook August 22, 2023August 22, 2023 0 Comments CMS, Healthcare Costs, medicare, Medicare Part D, Out-of-pocket prescription costs

CMS pitches guidance for Medicare Part D monthly payment plan: 5 things to know

(By Rylee Wilson for Becker’s Hospital Review) CMS published draft guidance for a new program that will allow Medicare Part

CMS Health Care Finance Health Care Redesign Part D/Prescription Drugs

Eileen Cook August 16, 2023August 16, 2023 0 Comments CMS, Drug-pricing, Medicare Drug Price Negotiation Program, Medicare Part D

The 10 drugs that CMS might wrangle into negotiations

(By Paige Twenter for Becker’s Hospital Review) CMS plans to soon release its list of 10 drugs that are up